Related Experiment Video
Updated: Jun 24, 2026

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS
Published on: August 10, 2017
Hydroxyurea and hydroxamic acid derivatives as antitumor drugs
1Laboratory for Systems Biomedicine, Division of Molecular Medicine, Rudjer Boskovic Institute, Bijenicka cesta 54, 10 000, Zagreb, Croatia. nsaban@irb.hr
Abstract:
Hydroxyurea has been used for decades and it is still valuable for the treatment of some types of cancer. It inhibits ribonucleotide reductase (RNR) enzyme known to be crucial in the conversion of ribonucleotides into deoxyribonucleotides. However, nowadays the main focus has shifted to structurally similar hydroxamic acid derivatives that target specific enzymes involved in cancer progression such as histone deacetylases, matrix metalloproteinases and also RNR.
Related Concept Videos
Antiviral Nucleoside Inhibitors
Drugs that Destabilize Microtubules
Antihypertensive Drugs: Thiazide-Class Diuretics
Drugs that Stabilize Microtubules
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
